(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
Lung cancer screening saves lives by detecting cancer early when it is most treatable. But what many people don’t realize is that the same low-dose CT scans used to screen for lung cancer can also ...
Researchers from Humana Healthcare Research and University of Chicago Medicine found that Medicare Advantage members with COPD and low medication adherence significantly improved their ...
Tozorakimab is an investigational monoclonal antibody designed to bind and inhibit interleukin-33 (IL-33), an alarmin cytokine. This targeted approach is expected to reduce airway inflammation and ...
AstraZeneca's IL-33-targeting antibody tozorakimab has hit the target in the third of three phase 3 trials in chronic ...
New FDA-approved medical treatments can be transformative for patients and families, often providing them with more years to live and an enhanced quality of life. 1 Delivering timely, high-quality ...
COPD treatments aim to improve patients' quality of life, with options including medication, rehabilitation, and invasive procedures. Emphysema significantly impacts patients' daily activities due to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In those with and those without emphysema, patients ...
Reviewed by Ware Kuschner, MD, Professor of Medicine, Division of Pulmonary, Allergy, & Critical Care Medicine, Stanford University School of Medicine Among adults with chronic obstructive pulmonary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results